Story at a glance:
- The FDA has authorized the use of a booster COVID-19 shot in children ages 5 to 11; less than one-third — only 28.8% — of U.S. children in this age group have received the first two doses of this experimental gene therapy.
- Effectiveness of COVID-19 shots in children wanes rapidly; a CDC study found that two to four weeks after the second dose of Pfizer’s COVID-19 shots, effectiveness was 60.1% among 5- to 11-year-olds, but this fell to just 28.9% by month two.
- There is still no data on whether the booster is effective against COVID-19, and whether the effectiveness will quickly wane, as it has with all previous shots as well as booster doses in adults.
- Artificially inflated antibodies triggered by booster shots signal to your body that you’re always infected, and the resulting immune response could prove to be detrimental to your health.
- COVID-19 shots are associated with liver injury, including liver failure that led to a liver transplant.
- Children are at extremely low risk of serious illness from COVID-19, and CDC data show that COVID-19 case rates among children who received two COVID-19 shots are now higher than rates in children who did not get the shots..
